Rachel Dear

Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre

Martin H.N. Tattersall, Rachel Dear, Jesse Jansen et al. · The Medical Journal of Australia · 2009 · 65 citations · Full text

Medicine, Oncology, Cancer Control +13

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Fabrice Barlési, Makoto Nishio, Manuel Cobo et al. · Annals of Oncology · 2018 · 49 citations

Medicine, Oncology, Pharmacology +12

Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach

Frank Lin, Adrian Pokorny, Christina T. Teng et al. · BMC Cancer · 2016 · 37 citations · Full text

Medicine, Oncology, Breast Oncology +15

64Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial

Keith Wong, Gemma Sheehan‐Dare, Andrew Nguyen et al. · Pharmaceuticals · 2022 · 36 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Exploring the communication of oncologists, patients and family members in cancer consultations: development and application of a coding system capturing family‐relevant behaviours (KINcode)

Rebekah Laidsaar‐Powell, Phyllis Butow, Stella Bu et al. · Psycho-Oncology · 2015 · 30 citations

Medicine, Oncology, Radiation Oncology +16